Metropolis Healthcare Ltd
NSE: METROPOLIS · Healthcare Service Provider · sector
₹530.00NSE close 2026-10-26
Key numbers
Market cap₹10,989 cr
Price₹530.00
52w high / low₹609 / ₹412
P/E54.5xSector median 22.9x
P/B7.3xSector median 2.0x
Book value₹73.0
Dividend yield0.19%Sector median 0.55%
ROE14.2%Sector median 5.4%
ROCE19.7%Sector median 6.8%
OPM24.2%Sector median 15.9%
Debt / equity0.01xSector median 0.07x
EV/EBITDA26.1xSector median 17.2x
Interest cover11.8x
Current ratio1.40x
Sales growth 3y+12.8%Sector median +13.5%
Profit growth 3y+10.0%Sector median +26.9%
PEG5.66x
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹203 cr vs borrowings ₹19 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 11.8x in the last 12 months.
- 1.21% of the promoters' shares are pledged (0.6% of all shares).
- Promoter holding fell by 1.07 percentage points in a year, to 47.82% (2026-09-30).
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 11% of net profit in the last 12 months.
- Dividend paid in 4 of the last 5 financial years.
- Price ₹530.00 on 2026-10-26: -13.0% from the 52-week high, +28.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹2,276.90 · low ₹424.25
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 350 | 323 | 345 | 386 | 429 | 406 | 425 | 450 |
| EBITDA | 90 | 72 | 62 | 90 | 108 | 86 | 108 | 111 |
| OPM % | 25.7% | 22.3% | 18.0% | 23.3% | 25.2% | 21.1% | 25.5% | 24.7% |
| Other income | 3 | 3 | 7 | 8 | 1 | 9 | 8 | 5 |
| Net profit | 47 | 31 | 29 | 45 | 53 | 41 | 51 | 57 |
| EPS (₹) | 2.27 | 1.53 | 1.42 | 2.17 | 2.54 | 2.00 | 2.46 | 2.73 |
| Revenue YoY | +22.7% | +25.8% | +23.0% | +16.6% | ||||
| Profit YoY | +13.2% | +32.0% | +74.7% | +25.8% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1,228 | 1,148 | 1,208 | 1,331 | 1,646 | 1,710 |
| EBITDA | 359 | 288 | 283 | 303 | 392 | 413 |
| Net profit | 214 | 143 | 128 | 145 | 190 | 202 |
| EPS (₹) | 10.47 | 6.98 | 6.24 | 7.07 | 9.19 | 9.73 |
| Revenue growth | -6.5% | +5.2% | +10.2% | +23.6% | +21.8% | |
| Profit growth | -33.3% | -10.5% | +13.4% | +31.1% | +32.6% | |
| Dividend / share (₹) | 8.00 | 8.00 | 4.00 | – | 4.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +12.8% | +10.5% | +21.8% |
| Net profit | +10.0% | +0.7% | +32.6% |
| EPS | +9.6% | +0.4% | – |
| Share price | – | -1.0% (2y) | +10.6% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 988 | 1,096 | 1,331 | 1,513 |
| Borrowings | – | 79 | 0 | 14 | 19 |
| Cash & equivalents | – | 106 | 124 | 118 | 203 |
| Total assets | – | 1,502 | 1,555 | 1,867 | 2,138 |
| Fixed assets | – | 137 | 156 | 190 | 215 |
| Capital work in progress | – | 0 | 0 | 0 | 0 |
| Investments | – | 2 | 2 | 2 | 2 |
| Receivables | – | 122 | 126 | 148 | 170 |
| Inventory | – | 45 | 39 | 48 | 45 |
| Payables | – | 94 | 99 | 126 | 129 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 253 | 247 | 264 | 263 | 351 |
| Cash from investing | -735 | 47 | -89 | -201 | -223 |
| Cash from financing | 163 | -292 | -181 | -87 | -115 |
| Capex | 31 | 53 | 64 | 69 | 51 |
| Free cash flow | 223 | 194 | 200 | 194 | 300 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 14.5% | 11.7% | 10.9% | 12.6% |
| ROCE % | – | 20.1% | 18.0% | 15.6% | 18.5% |
| Debtor days | – | 39 | 38 | 41 | 38 |
| Inventory days | – | 64 | 58 | 65 | 51 |
| Payable days | – | 136 | 150 | 171 | 146 |
| Cash conversion cycle (days) | – | -33 | -54 | -65 | -57 |
| Working capital days | – | 12 | 21 | 14 | 30 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 47.82% |
| FIIs | 11.67% |
| DIIs | 35.49% |
| of which Mutual funds | 33.09% |
| of which Insurance | 1.96% |
| Public (non-institutions) | 5.02% |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 48.90% | 48.89% | 48.89% | 48.88% | 48.87% | 48.87% | 48.86% | 47.82% |
| Promoter group | % |
|---|---|
| Metz Advisory LLP | 29.75% |
| Duru Shah Family Trust (Duru Sushil Shah & Sushil Kanubhai Shah) | 10.54% |
| Sushil Shah Family Trust (Sushil Kanubhai Shah & Duru Sushil Shah) | 7.18% |
| Ameera Sushil Shah | 0.35% |
| Sushil Kanubhai Shah | 0.00% |
| Hemant Sachdev | 0.00% |
| Mayur Shah | 0.00% |
| Amar Bajaj | 0.00% |
| Karma Shah Sachdev | 0.00% |
| Jahaan Shah Sachdev | 0.00% |
| Nandi Shah Sachdev | 0.00% |
| Geetika Advani | 0.00% |
| Sudesh Sachdev | 0.00% |
| Lata Sachdev | 0.00% |
| Sushil Shah HUF (Sushil Kanubhai Shah) | 0.00% |
| Public holders above 1% | % |
|---|---|
| Hdfc Mutual Fund - Hdfc Focused Fund | 9.66% |
| Franklin India Small Cap Fund | 5.22% |
| Kotak Small Cap Fund | 3.79% |
| Uti Value Fund | 2.81% |
| Aditya Birla Sun Life Mutual Fund - Aditya Birla Sun Life Flexi Cap Fund | 2.51% |
| Tata Business Cycle Fund | 2.26% |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 2.21% |
| Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund | 1.45% |
| Icici Prudential Healthcare Fund | 1.09% |
50,592 shareholders. Pledged: 1.21% of promoter shares.
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| ONEGLOBAL | ₹773 cr | 10.5x | 5.5x | 69.4% | 69.9% | 19.2% | +201.8% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-05-19 | Dividend | Interim Dividend - Re 1 Per Share |
| 2026-03-20 | Bonus | Bonus 3:1 |
| 2025-11-11 | Dividend | Interim Dividend - Rs 4 Per Share |
| 2023-11-17 | Dividend | Interim Dividend - Rs 4 Per Share |
| 2023-08-10 | Other | Annual General Meeting |
| 2023-02-23 | Dividend | Interim Dividend - Rs 8 Per Share |
| 2022-08-08 | Other | Annual General Meeting |
| 2022-02-21 | Dividend | Interim Dividend - Rs. 8 Per Share |
| 2021-02-17 | Dividend | Interim Dividend - Rs 8 Per Share |
| 2020-02-13 | Dividend | Interim Dividend - Rs 8 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Human health and social work activities: Diagnostic testing service provider, Soft radiology services (ECG, X-ray etc), and Clinical Trial Research Services
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | METROPOLIS |
| BSE code | 542650 |
| ISIN | INE112L01020 |
| Face value | ₹2.0 |
| Incorporated | 2000-11-10 |
| Website | www.metropolisindia.com |
| Plants (India / abroad) | 0 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.